Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Amplification of CRAC current by STIM1 and CRACM1 (Orai1).

Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M, Lis A, Fleig A, Penner R, Kinet JP.

Nat Cell Biol. 2006 Jul;8(7):771-3. Epub 2006 May 30.

2.

CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry.

Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet JP.

Science. 2006 May 26;312(5777):1220-3. Epub 2006 Apr 27.

3.

TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.

Stokes A, Wakano C, Koblan-Huberson M, Adra CN, Fleig A, Turner H.

Cell Signal. 2006 Oct;18(10):1584-94. Epub 2006 Feb 23.

PMID:
16500080
4.

Formation of a physiological complex between TRPV2 and RGA protein promotes cell surface expression of TRPV2.

Stokes AJ, Wakano C, Del Carmen KA, Koblan-Huberson M, Turner H.

J Cell Biochem. 2005 Mar 1;94(4):669-83.

PMID:
15547947
5.

A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells.

Stokes AJ, Shimoda LM, Koblan-Huberson M, Adra CN, Turner H.

J Exp Med. 2004 Jul 19;200(2):137-47. Epub 2004 Jul 12.

6.

RGA protein associates with a TRPV ion channel during biosynthesis and trafficking.

Barnhill JC, Stokes AJ, Koblan-Huberson M, Shimoda LM, Muraguchi A, Adra CN, Turner H.

J Cell Biochem. 2004 Mar 1;91(4):808-20.

PMID:
14991772
7.

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.

Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H.

J Immunol. 2003 May 15;170(10):4953-62.

Supplemental Content

Loading ...
Support Center